1) von der Mark K, Gauss V, von der Mark H, et al. Relationship between cell shape and type of collagen synthesised as chondrocytes lose their cartilage phenotype in culture. Nature 1977;267(5611):531-2.
2) Ansboro S, Roelofs AJ, De Bari C. Mesenchymal stem cells for the management of rheumatoid arthritis:immune modulation, repair or both? Curr Opin Rheumatol 2017;29(2):201-7.
3) Caplan AI. Adult mesenchymal stem cells:when, where, and how. Stem Cells Int 2015;2015:628767.
4) Nixon AJ, Begum L, Mohammed HO, et al. Autologous chondrocyte implantation drives early chondrogenesis and organized repair in extensive full- and partial-thickness cartilage defects in an equine model. J Orthop Res 2011;29(7):1121-30.
5) Farr J, Tabet SK, Margerrison E, et al. Clinical, radiographic, and histological outcomes after cartilage repair with particulated juvenile articular cartilage:a 2-year prospective study. Am J Sports Med 2014;42:1417-25.
6) Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007;131(5):861-72.
7) Yamashita A, Morioka M, Yahara Y, et al. Generation of scaffoldless hyaline cartilaginous tissue from human iPSCs. Stem Cell Reports 2015;4(3):404-18.
8) Yamashita A, Morioka M, Kishi H, et al. Statin treatment rescues FGFR3 skeletal dysplasia phenotypes. Nature 2014;513(7519):507-11.
9) Kimura T, Ozaki T, Fujita K, et al. Proposal of patient-specific growth plate cartilage xenograft model for FGFR3 chondrodysplasia. Osteoarthritis Cartilage 2018;26(11):1551-61.
10) Chen X, Yamashita A, Morioka M, et al. Integration capacity of human induced pluripotent stem cell-derived cartilage. Tissue Eng Part A 2019;25(5-6):437-43.
11) Kimura T, Yamashita A, Ozono K, et al. Limited immunogenicity of human induced pluripotent stem cell-derived cartilages. Tissue Eng Part A 2016;22(23-24):1367-75.